{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreia5amfvwxb37r4azndg7gsd4j3j4lfwyxow3lr65ztl6lta5mauoy",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3miflfnks3u72"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/03/31/pharma-delays-european-launches-lilly-biogen-deals-gilead/?utm_campaign=rss",
  "publishedAt": "2026-03-31T13:27:39.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "Drugmakers are delaying launches of some new medicines in Europe as the industry grapples with U.S. pressure ​and pricing policy shifts from President Trump",
  "title": "STAT+: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more",
  "updatedAt": "2026-03-31T13:27:43.000Z"
}